Perpetual Ltd’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,191
Closed -$226K – 397
2026
Q2
$226K Sell
1,191
-797
-40% -$150K ﹤0.01% 414
2026
Q1
$392K Sell
1,988
-815
-29% -$157K 0.01% 351
2025
Q4
$515K Sell
2,803
-4,257
-60% -$747K 0.01% 304
2025
Q3
$1.08M Sell
7,060
-1,913
-21% -$290K 0.01% 243
2025
Q2
$1.25M Sell
8,973
-2,911
-24% -$408K 0.01% 228
2025
Q1
$1.75M Sell
11,884
-253
-2% -$36.6K 0.02% 212
2024
Q4
$1.59M Sell
12,137
-9,708
-44% -$1.36M 0.02% 207
2024
Q3
$3.4M Sell
21,845
-3,511
-14% -$567K 0.04% 158
2024
Q2
$3.96M Buy
25,356
+1,739
+7% +$262K 0.04% 166
2024
Q1
$3.22M Buy
23,617
+3,098
+15% +$410K 0.03% 185
2023
Q4
$2.76M Sell
20,519
-312
-1% -$40.6K 0.03% 183
2023
Q3
$2.82M Sell
20,831
-1,677
-7% -$229K 0.03% 192
2023
Q2
$3.22M Sell
22,508
-53
-0.2% -$7.8K 0.03% 207
2023
Q1
$3.13M Buy
+22,561
New +$3.04M 0.03% 214
2020
Q3
$172K Buy
+1,567
New +$174K 0.01% 279

Other funds holding AZN

Perpetual Ltd's AZN Position: Q3 2026 in Review

Perpetual Ltd sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 1,191 shares — an estimated $226K sold.

Perpetual Ltd first reported a position in AZN in Q3 2020 and held it in 15 quarters. The position peaked at $3.96M in Q2 2024. 491 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Perpetual Ltd reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
  • Perpetual Ltd sold 1,191 AstraZeneca shares in Q3 2026, an estimated $226K.
  • Perpetual Ltd first reported a position in AstraZeneca in Q3 2020 and held it in 15 quarters.
  • Perpetual Ltd's AstraZeneca position peaked at $3.96M in Q2 2024.
  • 491 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Perpetual Ltd's 13F filing for Q3 2026, filed 13 Oct 2026.